Evidence map›Paper›PMID 26160613›Full record

ReviewNature reviews. Immunology2015

The multifaceted biology of plasmacytoid dendritic cells.

Melissa Swiecki, Marco Colonna

Abstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 695 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
695citing papers in PubMed, 2 pooled it
40.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

695 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,054 citations in OpenAlex.

  1. Frontiers in immunology · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Effects of Heat-KilledNutrients · 2024
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Biochemistry and biophysics reports · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

635 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Melissa Swiecki1] Department of Pathology and Immunology, Washington University School of Medicine, 425 S. Euclid Avenue, St Louis, Missouri 63110, USA. [2] Janssen Research &Development, LLC, Spring House, Pennsylvania 19477, USA.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, 425 S. Euclid Avenue, St Louis, Missouri 63110, USA.
Washington University in St. Louis · US

Funding

IMPACT OF PLASMACYTOID DENDRITIC CELLS ON TYPE I DIABETES PATHOGENESISK01DK095972 · NIDDK · WASHINGTON UNIVERSITY · PI SWIECKI, MELISSA · 2013 to 2014
$168k
NIDDK NIH HHS K01 DK095972NIDDK NIH HHS K01DK095972
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) are a unique DC subset that specializes in the production of type I interferons (IFNs). pDCs promote antiviral immune responses and have been implicated in the pathogenesis of autoimmune diseases that are characterized by a type I IFN signature. However, pDCs can also induce tolerogenic immune responses. In this Review, we summarize recent progress in the field of pDC biology, focusing on the molecular mechanisms that regulate the development and functions of pDCs, the pathways involved in their sensing of pathogens and endogenous nucleic acids, their functions at mucosal sites, and their roles in infection, autoimmunity and cancer.

Indexed as

Immunity, InnateAdaptive ImmunityAnimalsAntigen PresentationAutoimmune DiseasesAutoimmunityCytokinesDendritic CellsGene Expression RegulationHumansInterferon Type IMiceSignal TransductionVirus DiseasesCytokinesInterferon Type I

Identifiers

PMID26160613
PMCPMC4808588
OpenAlexW1652582743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.